Will Trazodone (antidepressant medication) show up on a toxicology (tox) screen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone Detection on Toxicology Screens

Trazodone is not detected on standard urine drug screening panels and will not show up as a positive result for common drugs of abuse. Standard toxicology screens typically test for specific drug classes (cannabinoids, cocaine, amphetamines, opioids, benzodiazepines, etc.), and trazodone does not cross-react with these immunoassays 1.

Key Points About Standard Drug Screening

  • Standard drug screening panels do not include trazodone as part of routine testing for drugs of abuse 1.

  • Routine toxicology screens use immunoassays that are designed to detect specific drug classes and their metabolites, and trazodone's chemical structure (a triazolopyridine derivative) does not trigger positive results on these standard panels 2, 3.

  • Many drugs are not included in standard screening panels, and healthcare providers must specifically request testing for suspected substances that fall outside routine panels 1.

When Trazodone Can Be Detected

  • Specific testing is required if there is clinical suspicion of trazodone toxicity or overdose - this would involve requesting a specific trazodone level or comprehensive toxicology analysis using gas chromatography-mass spectrometry 1.

  • Therapeutic blood concentrations of trazodone are approximately 0.5-2 mg/L, and specific quantitative testing can measure these levels when clinically indicated 1, 4.

  • In overdose situations, trazodone concentrations above 9 mg/L have been associated with fatalities, but detection requires specific testing beyond standard screening 4.

Clinical Implications

  • False-positive concerns are not applicable - trazodone will not cause a false-positive result for other drugs on standard immunoassay screening panels 1.

  • If trazodone detection is clinically necessary (such as in cases of suspected overdose with altered mental status), providers must specifically request trazodone levels or comprehensive toxicology testing from the laboratory 1.

  • Standard "medical clearance" toxicology screens performed in emergency departments or psychiatric evaluations will not identify trazodone use unless specifically requested 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antidepressant properties of trazodone.

Clinical pharmacy, 1982

Research

Postmortem forensic toxicology of trazodone.

Journal of forensic sciences, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.